How To Use HCPCS Code C9488
HCPCS code C9488 describes the injection of conivaptan hydrochloride, with a dosage of 1 mg. This code is used to identify the administration of this specific medication through a parenteral route. In this article, we will explore the details of HCPCS code C9488, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.
1. What is HCPCS C9488?
HCPCS code C9488 is a specific code used to identify the injection of conivaptan hydrochloride, with a dosage of 1 mg. This code is used to indicate the administration of this medication through a parenteral route. It is important to use this code accurately to ensure proper documentation and billing for this specific procedure.
2. Official Description
The official description of HCPCS code C9488 is “Injection, conivaptan hydrochloride, 1 mg.” The short description for this code is “Parenteral supp not othrws c.” This official description provides a clear and concise explanation of the procedure being performed.
3. Procedure
- The provider prepares the conivaptan hydrochloride medication for injection.
- The provider ensures proper patient identification and verifies the correct dosage of 1 mg.
- The provider selects an appropriate injection site and cleanses the area with an antiseptic solution.
- The provider uses a sterile syringe and needle to administer the conivaptan hydrochloride injection.
- After the injection, the provider disposes of the used syringe and needle in a proper sharps container.
- The provider documents the administration of the conivaptan hydrochloride injection in the patient’s medical record.
4. When to use HCPCS code C9488
HCPCS code C9488 should be used when the provider administers an injection of conivaptan hydrochloride with a dosage of 1 mg. It is important to use this code only when the specific medication and dosage are administered through a parenteral route. Other routes of administration may require different HCPCS codes.
5. Billing Guidelines and Documentation Requirements
When billing for HCPCS code C9488, healthcare providers should ensure proper documentation of the procedure. This includes documenting the administration of the conivaptan hydrochloride injection, the dosage of 1 mg, and the route of administration (parenteral). Additionally, providers should follow the billing guidelines set forth by the relevant insurance carriers to ensure accurate and timely reimbursement.
6. Historical Information and Code Maintenance
HCPCS code C9488 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. There have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code. This code has remained unchanged since its addition to the HCPCS.
7. Medicare and Insurance Coverage
HCPCS code C9488 may be covered by Medicare and other insurance carriers. The pricing indicator code for this code is 57, which indicates that it is priced by other carriers. The multiple pricing indicator code is A, which means it is not applicable as HCPCS priced under one methodology. Providers should check with the specific insurance carriers for coverage and reimbursement guidelines.
8. Examples
Here are five examples of when HCPCS code C9488 should be billed:
- A patient with a diagnosed condition requiring the administration of conivaptan hydrochloride via a parenteral route.
- A patient undergoing a medical procedure that necessitates the use of conivaptan hydrochloride as part of the treatment.
- A patient with a documented allergy to other medications, requiring the use of conivaptan hydrochloride as an alternative.
- A patient participating in a clinical trial where the administration of conivaptan hydrochloride is part of the study protocol.
- A patient with a specific medical condition that has been shown to benefit from the use of conivaptan hydrochloride.
